Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Pembrolizumab + Anti-platelet Therapy for Head and Neck Cancer
Recruiting1 awardPhase 1
Charleston, South Carolina
This trial is testing if combining two treatments works better than using one treatment alone for patients with head and neck cancer that has come back or spread. The combination aims to improve the immune system's ability to fight the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.